Kathleen L. Miller

Latest Institution: US Food and Drug Administration

All Institutions: US Food and Drug Administration


Causal Claims Network Graph

Edges that are evidenced by causal inference methods are in orange, and the rest are in light blue.

Based on the Following Papers:

Regulatory Incentives for Innovation: The FDA's Breakthrough Therapy Designation

Year: 2022
Journal: No Journal Matched
Authors: Amitabh Chandra; Jennifer Kao; Kathleen L. Miller; Ariel D. Stern


Author Disambiguation

This page includes results for all related names (only one name shown, no other authors with similar names):

Back to index